[ad_1]
High doses of the vitamin to treat COVID-19 infection could have beneficial effects for a large portion of the population. However, the researchers believe that this depends on the levels of the natural transporter necessary to carry the vitamin into cells. Experts from the Medical College of Georgia say that the age, sexuality, expression levels and genetic variations of vitamin C carriers should be considered when estimating efficacy against coronavirus, according to Medicalxpress.
“All of these factors need to be considered in the design and conduct of clinical trials, and in studies of COVID-19, but also in studies of other diseases,” says Dr. Sadanand Fulzele, lead author of the study.
Ursula von der Leyen announces YEAR: the Covid-19 vaccine will go on sale in December in the European Union
More and more studies have been started around the world aimed at finding a treatment for COVID-19. The research also includes studying the efficacy of known medications, including vitamin C, known as an immune system enhancer.
At least 30 clinical trials are underway to evaluate the efficacy of this vitamin. Some of the studies test doses up to 10 times higher than the usual recommended levels.
“Clinical trials for osteoarthritis, for example, an autoimmune disease in which the immune system attacks the joints, have had mixed results. However, its use in other conditions, such as those induced by viruses, has shown benefits in reducing insufficiency. organic and improve lung function, in acute respiratory distress syndrome, a major cause in severe cases of COVID-19 and which can lead to death, “explains Dr. Fuzele.
[ad_2]
